Galeon, a pioneering AI-driven health community, allocates €500,000 for drug repurposing without profit expectations, inviting global medical experts' insights.

This innovative endeavor aims to repurpose existing drugs for new therapeutic uses, revolutionizing medical research through its first-ever DAO implementation.

By accelerating drug repurposing, Galeon aims to expedite the discovery of new treatments, emphasizing collaboration and decentralized science.

The initiative underscores Galeon's dedication to advancing medical research and addressing global healthcare challenges effectively.

This bold move by Galeon signifies a paradigm shift in medical science, fostering innovation and agility in research funding and drug development.